vasoglide
vasoglide

N-ovative Health Technologies (NHT) introduces VASOGLIDE®; Pakistan’s first locally manufactured Rapid Exchange Balloon Catheter which is intended for use during Percutaneous Transluminal Coronary Angioplasty (PTCA) to improve myocardial blood flow in the localised stenotic lesion of the coronary arteries.

Key Features
  • Excellent biocompatibility
  • Optimum durability
  • Optimum lesion crossing profile
  • Radio-opaque markers
  • Wide variety of sizes available
  • Outstanding deliverability
    • - Hydrophilic coated distal shaft
      - Superior trackability
      - Low lesion entry profile

VASOGLIDE Technical and Performance Specifications

Nominal Pressure (NP) 6 - 8 atm
Rated Burst Pressure (RBP) 12 -14 atm
Lesion Entry Profile 0.44 mm
Useable Length 1400 mm (approx.)
Coating Hydrophilic
Balloon Length (mm)
Balloon Catheter Diameter (mm) 12 16 20 26 30
2.0 B20012 B20016 B20020 B20026 B20030
2.5 B25012 B25016 B25020 B25026 B25030
3.0 B30012 B30016 B30020 B30026 B30030
3.5 B35012 B35016 B35020 B35026 B35030
4.0 B40012 B40016 B40020 B40026 B40030
Product Registration Number: MDMR-000080
CE Certification is in process
Product Readiness

VASOGLIDE®has successfully passed the following clinical evaluation stages:

  1. Physico-Chemical Testing – conducted at Heinz Schade, GmbH, Germany
  2. Animal trials – conducted at American Heart of Poland, Center for Cardiovascular Research and Development, Katowice, Poland (as delivery system)
  3. Human trials – Conducted in coordination with top scientists at Emory University, Atlanta, Georgia, USA (as delivery system)
  4. Human trials (local) - conducted at the following institutes:-
    a. Rawalpindi Institute of Cardiology (RIC), Rawalpindi, Pakistan
    b. National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
  5. Registration by Drug Regulatory Authority of Pakistan (DRAP)
vasoglide

Product Illustrations

Copyright 2020 | All Rights Reserved
google twitter LinkedIn